A pleasure to speak to the Simply Oncology team about head & neck cancer in my podcast debut

New episode of Simply Oncology coming for Head and Neck patients. 🎙️We speak to the superb @clairepaterson.bsky.social about radiotherapy and new treatments in H&N cancers. 🎙️A great resource for any patient undergoing H&N treatment @simplyoncology.bsky.social

Our April 1 podcast is no joke! featuring three heavy hitters in #hncsm. At: www.redjournal.org/audio-do/red... Pro tip: right click on the play bar and download the audio file for better listening OMET trial: www.redjournal.org/article/S036... Fabulous editorial: www.redjournal.org/article/S036...

Our Scottish Cancer Registry analysis shows that behind stable head & neck cancer incidence rates over the past 20 years, there are highly variable differential trends in anatomical subsites @clairepaterson.bsky.social @uofglasgow.bsky.social #MVLSCollege #GLAHNC pubmed.ncbi.nlm.nih.gov/39800346/

This is a fascinating trial Same survival chemo-SABR 42.3 months vs SABR-alone 41.1 months in #hncsm patients with oligomets GORTEC 2014-04 “OMET” Randomized Phase 2 Trial in Head and Neck Cancer Patients with Oligometastases using SABR-alone or chemotherapy-SABR 👉 www.redjournal.org/article/S036...

Exclusive tip for bsky friends only - deadline for the Adaptive Cancer Therapies special issue has been extended to Nov 30 ... One more week to grab your seat on the Adaptive canoe! (don't do rocketships on bsky) #IJROBP

@ESTRO_RT abstract submitted with over 24 hours till deadline 😇 thanks to the wonderful Adam Peters @UofGMVLS & @onctrainees . Now time to 🤞 and hope we’re off to Vienna in May 2025 ✈️ #radonc #hncsm